- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 588820 [Title] => Roche drug helps women with ovarian cancer live longer [Summary] =>Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the continuation of bevacizumab alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
[DatePublished] => 2010-07-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
GYNECOLOGIC ONCOLOGY GROUP
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 588820 [Title] => Roche drug helps women with ovarian cancer live longer [Summary] =>Roche recently announced results from a Phase III study of bevacizumab that showed women with previously untreated advanced ovarian cancer who received bevacizumab in combination with chemotherapy, followed by the continuation of bevacizumab alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.
[DatePublished] => 2010-07-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
EZ2/LVM - 10 10
SUERTRES - 2 8 3
6D Lotto - 9 2 9 8 5 8
6/42 - 20 39 22 7 9 1
P23,586,438.00
Grand Lotto - 10 28 3 53 41 20
P40,549,068.00
- 12:00 am